Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroi... CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.3113 | 44.4714285714 | 0.7 | 1.14 | 0.6705 | 101426 | 0.70776019 | CS |
| 4 | -0.3287 | -24.5298507463 | 1.34 | 2.89 | 0.6705 | 2781364 | 1.02422232 | CS |
| 12 | 0.5773 | 133.01843318 | 0.434 | 11 | 0.3927 | 1016408 | 1.34704148 | CS |
| 26 | -0.6087 | -37.5740740741 | 1.62 | 11 | 0.37 | 800071 | 1.24958729 | CS |
| 52 | -1.2887 | -56.0304347826 | 2.3 | 11 | 0.37 | 1840978 | 0.98817338 | CS |
| 156 | -11.5887 | -91.9738095238 | 12.6 | 12.89 | 0.04 | 7885056 | 0.32925533 | CS |
| 260 | -11.5887 | -91.9738095238 | 12.6 | 12.89 | 0.04 | 7885056 | 0.32925533 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
